Human T-cell leukemia virus

Renewed research focus on the human T-cell leukemia virus

Nov 9, 2018

Human T-cell leukemia virus-1(HTLV-1) is the only known retrovirus to directly cause cancer in humans. Infection with this retrovirus affects millions of people worldwide, but currently there is neither a targeted antiretroviral therapy nor a vaccine available. “The discovery of novel preventive or therapeutic remedies for this retrovirus could relieve not only the suffering of HTLV-1 infected individuals but also augment understanding of other chronic infections with cancer viruses,” says Genoveffa Franchini, M. D., Senior Investigator in the CCR Vaccine Branch who has conducted pioneering work on the retrovirus. Read more...

Lung cancer cells

Lung Cancer Research

Nov 1, 2018

November is Lung Cancer Awareness Month. Our research portfolio includes investigators making important discoveries in lung cancer research.  Read more...

pancreatic cancer cells

Pancreatic Cancer Research

Nov 1, 2018

November is Pancreatic Cancer Awareness Month. We have many researchers, both in the basic and clinical disciplines, who are working on pancreatic cancer.  Learn more...

Perwez Hussain

Recap: The 5th NCI Pancreatic Cancer Symposium

Oct 15, 2018

The 5th NCI Pancreatic Cancer Symposium took place on October 2-3, 2018, and was attended by about 300 participants from across the United States and abroad. This year’s symposium was jointly organized by the NCI Pancreatic Cancer Interest Group and the Medical University of Gottingen, Germany. The symposium covered the latest advancements in the field and provided novel insights in the area of early detection, epidemiology, tumor biology including metabolic reprograming and inflammatory/immune signaling and tumor stromal interaction, and it highlighted the challenges in developing treatment strategies to improve patient outcomes.  Read more...

breast cancer in a dish

Breast Cancer Research

Oct 1, 2018

To recognize Breast Cancer Awareness Month this October, we are highlighting our researchers who are making discoveries in this field. Read more…

Lymphoma

Our leukemia and lymphoma research

Sep 4, 2018

September is leukemia and lymphoma awareness month. Lymphoma is a broad term for cancer that begins in cells of the lymph system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Leukemia is a broad term for cancers of the blood cells. The type of leukemia depends on the type of blood cell that becomes cancer and whether it grows quickly or slowly. To learn more about our leukemia and lymphoma research, click here.

Steven Pavletic

Steven Pavletic elected as corresponding member of the Croatian Academy of Arts and Sciences

Jun 28, 2018

Steven Pavletic, M.D., Senior Clinician in the Experimental Transplantation and Immunology Branch, has been elected as a corresponding member of the Croatian Academy of Sciences and Arts. Dr. Pavletic was honored during a ceremony on June 14 at the Palace of the Academy in Zagreb, Croatia. Read more...

Steven Pavletic elected as corresponding member of the Croatian Academy of Arts and Sciences
Killer T cell

CCR: A history of advancing the field of immunology

Jun 26, 2018

The Center for Cancer Research has been at the forefront in the field of immunology and immunotherapy for decades. Our scientists have made seminal findings that have opened doors to new research areas and treatment approaches for cancer patients. Use this timeline to explore our rich history at the cutting edge of research towards understanding the immune system and harnessing its power to treat cancer. Read more...

CCR: A history of advancing the field of immunology
VHL

25 years ago: CCR scientists discover first gene linked to kidney cancer

May 29, 2018

Twenty-five years ago, NCI scientists uncovered the VHL gene, a gene whose mutation can lead to the development of kidney tumors. The discovery, the result of a decade-long partnership between CCR scientists, including W. Marston Linehan, M.D., Chief of CCR’s Urologic Oncology Branch, and families affected by the disease, paved the way for new targeted therapies that have improved the prognosis for patients with advanced kidney cancers.  Read more...

brain tumor facebook live

Facebook Live: Adult brain and spine tumor research and treatment

May 23, 2018

Please join us for a Facebook Live on adult brain and spine tumor research and treatment May 25 at 11:00 a.m. ET.. The conversation will focus on primary central nervous system (CNS) tumors, meaning the tumor begins in the brain or spinal cord. Mark Gilbert, M.D., Chief, and Terri Armstrong, M.D., Senior Investigator, both from the Neuro-Oncology Branch, will be joined by moderator and Chief Executive Officer, David Arons, of the National Brain Tumor Society.  Read more...

Facebook Live: Adult brain and spine tumor research and treatment

Pages